Literature DB >> 18070143

Evaluation of adrenal function using the human corticotrophin-releasing hormone test, low dose Synacthen test and 9am cortisol level in children and adolescents with central adrenal insufficiency.

Ann M Maguire1, Cornelis J Biesheuvel, Geoffrey R Ambler, Bin Moore, Mark McLean, Christopher T Cowell.   

Abstract

BACKGROUND: The insulin tolerance test (ITT) has become less popular in paediatrics because of the risks associated with hypoglycaemia. Human corticotrophin-releasing hormone (hCRH) test results correlate with the ITT and may be an acceptable method to test for central adrenal insufficiency (CAI). Simpler tests, such as the low dose Synacthen test (LDST) and 9am cortisol, have also been proposed.
OBJECTIVE: To compare the ability of the hCRH test, LDST, 9am cortisol level and 24-h cortisol profiles to diagnose CAI in a paediatric population. DESIGN AND
SETTING: A cross-sectional study in a tertiary paediatric endocrine clinic. PARTICIPANTS: Thirty-one children and adolescents (aged 2.3-18.3 years) with CAI risk factors had an hCRH test, LDST, 9am cortisol and 24-h cortisol profile performed.
RESULTS: Of 23 patients with confirmed CAI (hCRH peak cortisol < 400 nmol/), 19 failed the LDST (peak cortisol < 267 nmol/l, i.e. 10th percentile for controls). Nineteen would have failed based on the 10th percentile cut point for 9am cortisol (< 140 nmol/l). Using receiver operating characteristic (ROC) curve coordinates, a 9am cortisol < 108 nmol/l was sensitive (83%) and specific (99%) for CAI. The 9am cortisol levels measured on two occasions were repeatable (94%) and correlated (r = 0.83, P = 0.01). All eight adrenally sufficient patients (hCRH peak cortisol > or = 400 nmol/l) passed the LDST. Seven had normal 9am cortisol (> or = 140 nmol/l). The 24-h cortisol area under the curve (AUC) for these patients was within the 10th-90th percentiles for control subjects' AUC. The peak cortisol to hCRH and LDST were correlated (r = 0.88, P = 0.01), with no difference between the peaks (mean difference -5.3 nmol/l, P = 0.69).
CONCLUSIONS: In children with CAI risk factors, the diagnosis can be made if unstressed 9am cortisol is < 108 nmol/l. As cortisol levels > 381 nmol/l are highly suggestive of normal hypothalamic-pituitary-adrenal (HPA) function, stimulation testing need only be performed if 9am cortisol is 108-381 nmol/l. The LDST should be interpreted cautiously because mild CAI may be missed. When stimulation results are marginal, 24-h cortisol profiles can provide reassurance of normal cortisol status.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18070143     DOI: 10.1111/j.1365-2265.2007.03100.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

1.  Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug.

Authors:  Laurie S Conklin; Jesse M Damsker; Eric P Hoffman; William J Jusko; Panteleimon D Mavroudis; Benjamin D Schwartz; Laurel J Mengle-Gaw; Edward C Smith; Jean K Mah; Michela Guglieri; Yoram Nevo; Nancy Kuntz; Craig M McDonald; Mar Tulinius; Monique M Ryan; Richard Webster; Diana Castro; Richard S Finkel; Andrea L Smith; Lauren P Morgenroth; Adrienne Arrieta; Maya Shimony; Mark Jaros; Phil Shale; John M McCall; Yetrib Hathout; Kanneboyina Nagaraju; John van den Anker; Leanne M Ward; Alexandra Ahmet; Michaelyn R Cornish; Paula R Clemens
Journal:  Pharmacol Res       Date:  2018-09-13       Impact factor: 7.658

2.  Adrenal Insufficiency in Pediatric Eosinophilic Esophagitis Patients Treated with Swallowed Topical Steroids.

Authors:  Stephanie Hsu; Colleen Wood; Zhaoxing Pan; Haseeb Rahat; Philip Zeitler; David Fleischer; Calies Menard-Katcher; Glenn T Furuta; Dan Atkins
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2017-09-01       Impact factor: 1.349

Review 3.  Adrenal suppression from exogenous glucocorticoids: Recognizing risk factors and preventing morbidity.

Authors:  Alexandra Ahmet; Anne Rowan-Legg; Larry Pancer
Journal:  Paediatr Child Health       Date:  2021-06-11       Impact factor: 2.600

Review 4.  Glucocorticoid treatment in juvenile idiopathic arthritis.

Authors:  Ezgi Deniz Batu
Journal:  Rheumatol Int       Date:  2018-10-01       Impact factor: 2.631

5.  Clinical and Biochemical Features of Hypopituitarism Among Brazilian Children With Zika Virus-Induced Microcephaly.

Authors:  Leda L Ferreira; Juan P Aguilar Ticona; Paulo S Silveira-Mattos; María B Arriaga; Thaisa B Moscato; Gildásio C Conceição; Antonio Carlos Dos Santos; Federico Costa; Crésio A D Alves; Sonir R Antonini
Journal:  JAMA Netw Open       Date:  2021-05-03

6.  Should Pediatric Endocrinologists Consider More Carefully When to Perform a Stimulation Test?

Authors:  Arturo Penco; Benedetta Bossini; Manuela Giangreco; Viviana Vidonis; Giada Vittori; Nicoletta Grassi; Maria Chiara Pellegrin; Elena Faleschini; Egidio Barbi; Gianluca Tornese
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-22       Impact factor: 5.555

Review 7. 

Authors:  Alexandra Ahmet; Anne Rowan-Legg; Larry Pancer
Journal:  Paediatr Child Health       Date:  2021-06-11       Impact factor: 2.600

8.  Adrenal suppression in children treated with swallowed fluticasone and oral viscous budesonide for eosinophilic esophagitis.

Authors:  Alexandra Ahmet; Eric I Benchimol; Ellen B Goldbloom; Janice L Barkey
Journal:  Allergy Asthma Clin Immunol       Date:  2016-10-10       Impact factor: 3.406

9.  Screening practices for paediatric asymptomatic adrenal suppression in Canada: Are we addressing this important risk?

Authors:  Ellen B Goldbloom; Alexandra Ahmet
Journal:  Paediatr Child Health       Date:  2019-03-30       Impact factor: 2.253

10.  Peak cortisol response to corticotropin-releasing hormone is associated with age and body size in children referred for clinical testing: a retrospective review.

Authors:  Mary Ellen Vajravelu; Jared Tobolski; Evanette Burrows; Marianne Chilutti; Rui Xiao; Vaneeta Bamba; Steven Willi; Andrew Palladino; Jon M Burnham; Shana E McCormack
Journal:  Int J Pediatr Endocrinol       Date:  2015-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.